Subscribe to RSS
DOI: 10.1055/s-2004-815397
A Novel Total Synthesis of Indolo[2,3-b]naphthalene-6,11-diones
Publication History
Publication Date:
12 January 2004 (online)
Abstract
A new total synthesis of indolo[2,3-b]naphthalene-6,11-diones is described, which involves a novel opening of 2-(2′-nitrophenyl)-2-methoxycarbonyl-1-indanones to 2-[2-methoxycarbonyl-2-(2-nitrophenyl)ethyl]benzoic acids followed by a two-steps transformation of the latter into 2-(1H-indol-3-ylmethyl)benzoic acid methyl esters, which are then converted into the target compounds in three steps.
Key words
indoles - carbazoles - quinones
- 1
Thomson RH. Naturally Occurring Quinones 4th ed.: Chapman and Hall; London / New York: 1997. - 2
Cheng CC. In Progress in Medicinal Chemistry, Structural Aspects of Antineoplastic Agents - A New Approach Vol. 25:Ellis GP.West GB. Elsevier; Amsterdam: 1988. -
3a
Seghal SN.Czerkawski H.Kudelski A.Pandev K.Saucier R.Vézima C. J. Antibiot. 1983, 36: 355 -
3b
Findlay JA.Liu JS.Radics L.Rakhit S. Can. J. Chem. 1981, 59: 3018 -
3c
Findlay JA.Liu JS.Radics L. Can. J. Chem. 1983, 61: 323 -
3d
Singh K. J. Antibiot. 1984, 37: 71 - 4
Husson H.-P. In The Alkaloids, Chemistry and Pharmacology Vol. 26:Brossi A. Academic Press, Inc.; Orlando: 1985. Chap. 1. p.1-51 - 5
Luo Y.-L.Chou T.-C.Cheng CC. J. Heterocycl. Chem. 1996, 33: 113 -
6a
Macias-Ruvalcaba N.Cuevas G.Gonzalez I.Aguilar-Martinez M. J. Org. Chem. 2002, 67: 3673 -
6b
Hagelin H.Oslob JD.Akermark B. Chemistry 1999, 5: 2413 -
6c
Luo Y.-L.Chou T.-C.Cheng CC. J. Heterocycl. Chem. 1996, 33: 113 -
6d
Knoelker H.-J.O’Sullivan N. Tetrahedron 1994, 50: 10893 -
6e
O’Sullivan PJ.Moreno R.Murphy WS. Tetrahedron Lett. 1992, 33: 535 -
6f
Bittner S.Krief P.Massil T. Synthesis 1991, 215 -
7a
Cruces J.Martinez E.Treus M.Martinez LA.Estevez JC.Estevez RJ.Castedo L. Tetrahedron 2002, 58: 3015 -
7b
Estevez JC.Estevez RJ.Castedo L. Tetrahedron Lett. 1993, 34: 6479 - 8
Cruces J.Estevez JC.Castedo L.Estevez RJ. Tetrahedron Lett. 2001, 42: 4825 - 9
Barcia JC.Cruces J.Estevez JC.Estevez RJ.Castedo L. Tetrahedron Lett. 2002, 43: 5141 -
10a
Boogaard AT.Pandit UK.Koomen G.-J. Tetrahedron 1994, 50: 4811 -
10b
Rajeswaran WG.Srinivasan PC. Synthesis 1994, 270 -
10c
Griffith WP.Ley SV.Whitcombe GP.White AD. J. Chem. Soc., Chem. Commun. 1987, 1625 -
10d
Liebeskind LS.Iyer S.Jewell CF. J. Org. Chem. 1986, 51: 3065 -
10e
Ketcha DM.Gribble GW. J. Org. Chem. 1985, 50: 5451 -
12a
Saxton JE. In The Chemistry of Heterocyclic Compounds John Wiley and Sons; New York: 1994. -
12b
Gribble GW. J. Chem. Soc., Perkin Trans. 1 2000, 7: 1045 -
12c
Gribble GW. In Second Supplement to the 2nd Edition of Rodd’s Chemistry of Carbon Compounds, Heterocyclic CompoundsSainsbury M. Elsevier Science Publications; Amsterdam: 1997. -
12d
Bosch J.Bonjoch J.Amat M. The Alkaloids 1996, 48: 75-189 -
13a
Brown DW.Mahon MF.Ninan A.Sainsbury M.Shertzer HG. Tetrahedron 1993, 49: 8919 -
13b
Sainsbury M, andShertzer HG. inventors; Eur. Pat. Appl., EP 91-309445 19911015. -
13c
Shertzer HG.Sainsbury M. Food Chem. Toxicol. 1991, 29: 391 -
13d
Brown DW.Graupner PR.Sainsbury M.Shertzer HG. Tetrahedron 1991, 47: 4383 -
13e
Reboredo FJ.Treus M.Estévez JC.Estévez RJ.Castedo L. Synlett 2002, 999 -
14a
Joseph B.Alagille D.Merour J.-Y.Leonce S. Chem. Pharm. Bull. 2000, 48: 1872 -
14b
Joseph B.Alagille D.Rousseau C.Merour J.-Y. Tetrahedron 1999, 55: 4341 -
14c
McLean J.Peesapati V.Proctor GR. J. Chem. Soc., Perkin Trans. 1 1979, 98 -
14d
Fujimori K.Yamane K. Bull. Chem. Soc. 1974, 47: 1951 -
14e
Yamane K.Fujimori K. Bull. Chem. Soc. 1972, 45: 269 -
15a
Gribble GW. In The Alkaloids Vol. 39:Brossi A. Academic Press, Inc.; New York: 1990. Chap. 7. p.239-243 -
15b
Husson H.-P. In The Alkaloids, Chemistry and Pharmacology Vol. 26:Brossi A. Academic Press, Inc.; Orlando: 1985. Chap. 1. p.1-51 -
15c
Chakraborty DP. In The Alkaloids, Chemistry and Pharmacology Vol. 44:Cordell GA. Academic Press, Inc.; San Diego: 1993. Chap. 4. p.257-364 -
15d
Sengupta SK.Cheng XCC. In Cancer Chemotherapeutic AgentsFoye WO. ACS Professional Reference Books; Washington /DC: 1995. p.246-251
References
All new compounds gave satisfactory analytical and spectroscopic data. Selected physical and spectroscopic data are as follows. Compound 3a: Mp 135-137 ºC (MeOH). 1H NMR (CDCl3): δ = 1.16 (t, J = 7.0 Hz, 3 H, CH3), 3.37 (d,
J = 18.0 Hz, 1 H, CHH), 4.12-4.17 (m, 2 H, CH2O), 4.57 (d, J = 18.0 Hz, 1 H, CHH), 7.23-7.25 (m, 1 H, ArH), 7.44-7.54 (m, 4 H, 4 × ArH), 7.68-7.71 (m, 1 H, ArH), 7.90 (d, J = 8.0 Hz, 1 H, ArH), 8.09 (dd, J = 8.1 Hz and J′ = 1.5 Hz, 1 H, ArH).
13C NMR (CDCl3): δ = 13.8 (CH3), 42.5 (CH2), 62.6 (CH2), 65.6 (C), 125.1 (CH), 125.8 (CH), 126.6 (CH), 128.1 (CH), 128.5 (CH), 129.6 (CH), 133.6 (CH), 135.0 (C), 135.6 (C), 136.4 (CH), 148.8 (C), 153.7 (C), 168.1 (C=O), 201.2 (C=O). MS (CI): m/z (%) = 326(1) [M+ + 1], 47(100). Compound 4a: Oil. 1H NMR (CDCl3): 3.42-3.49 (m, 1 H, CHH), 3.64 (s, 3 H, CO2Me), 3.93-4.00 (m, 1 H, CHH), 4.72 (t, J = 8.0 Hz, 1 H, CH), 6.96 (d, J = 9.0 Hz, 1 H, ArH), 7.21-7.30 (m, 2 H, 2 × ArH), 7.34-7.53 (m, 3 H, 3 × ArH), 7.81-7.91 (m, 2 H, 2 × ArH). 13C NMR (CDCl3): δ = 37.4 (CH2), 47.8 (CH), 52.1 (OMe), 52.3 (OMe), 124.6 (CH), 126.7 (CH), 127.9 (CH), 129.5 (C), 130.8 (CH), 130.9 (CH), 131.6 (CH), 131.7 (CH), 132.7 (CH), 133.2 (C), 139.8 (C), 149.1 (C), 167.4 (C=O), 172.4 (C=O). MS (FAB): m/z (%) = 344(22) [M+ + 1], 149(100). Compound 5a: Mp 110-112 ºC (MeOH). 1H NMR (CDCl3): δ = 3.22-3.32 (m, 1 H, CHH), 3.83-3.91 (m, 5 H, CHH, CH, CO2Me), 6.66 (d, J = 7.5 Hz, 1 H, ArH), 6.84-6.89 (m, 2 H, 2 × ArH), 7.13-7.19 (m, 1 H, ArH), 7.29-7.49 (m, 3 H, 3 × ArH), 7.99 (m, 1 H, ArH), 8.81 (br s, 1 H, NH). 13C NMR (CDCl3): δ = 35.6 (CH2), 46.8 (CH), 52.1 (OMe), 109.6 (CH), 121.7 (CH), 124.9 (CH), 126.8 (CH), 127.7 (CH), 129.1 (C), 129.8 (C), 131.0 (CH), 131.7 (CH), 132.5 (CH), 139.9 (C), 141.3 (C), 167.6 (C=O), 179.6 (C=O). MS: m/z (%) = 281(13) [M
+
], 220(100). Compound 6a: Mp 111-113 ºC (MeOH). 1H NMR (CDCl3): δ = 3.95 (s, 3 H, CO2Me), 4.49 (d, J = 10 Hz, 2 H, CH2), 6.99-7.42 (m, 6 H, 6 × ArH), 7.92 (d, J = 7.5 Hz, 1 H, ArH), 8.16 (s, 1 H, ArH). 13C NMR (CDCl3): δ = 28.7 (CH2), 52.2 (OMe), 109.4 (C), 110.3 (CH), 113.2 (C), 113.7 (C), 118.7 (CH), 120.0 (CH), 122.2 (CH), 125.8 (CH), 127.8 (C), 129.5 (CH), 130.3 (CH), 131.8 (CH), 136.1 (C), 141.1 (C), 168.3 (C=O). MS (CI): m/z (%) = 345(18) [M+ + 2], 343(22) [M+], 264(100). Compound 6b: Mp 56-58 ºC (MeOH). 1H NMR (CDCl3): δ = 3.87 (s, 3 H, CO2Me), 4.54 (s, 2 H, CH2), 6.82 (s, 1 H, CH), 7.10-7.41 (m, 5 H, 5 × ArH), 7.58 (d, J = 8.0 Hz, 1 H, ArH), 7.91-7.99 (m, 2 H, 2 × ArH). 13C NMR (CDCl3): δ = 29.5 (CH2), 51.9 (OMe), 110.9 (CH), 115.2 (C), 118.9 (CH), 119.1 (CH), 121.8 (CH), 122.5 (CH), 125.8 (CH), 127.4 (C), 129.8 (C), 130.2 (CH), 130.7 (CH), 131.7 (CH), 136.2 (C), 142.3 (C), 168.4 (C=O). MS: m/z (%) = 265(66) [M+], 204(100). Compound 7a: Mp 206-208 ºC (MeOH). 1H NMR (CDCl3-acetone-DMSO): δ = 3.77 (s, 3 H, OMe), 6.61 (d, J = 5.0 Hz, 1 H, CH), 6.84 (m, 2 H, 2 × ArH), 7.04 (d, J = 5.0 Hz, 1 H, ArH), 7.47-7.59 (m, 3 H, 3 × ArH), 8.05 (s, 2 H, 2 × ArH), 9.35 (br s, 1 H, NH). 13C NMR (CDCl3-acetone-DMSO): δ = 51.4 (OMe), 109.3 (CH), 120.4 (CH), 120.9 (C), 122.0 (CH), 126.7 (C), 128.3 (C), 128.4 (CH), 128.8 (CH), 129.1 (CH), 130.3 (CH), 131.7 (CH), 136.2 (CH), 136.2 (C), 141.8 (C), 165.5 (C=O), 168.3 (C=O). MS: m/z (%) = 279(1) [M+], 58(100). Compound 8b: Mp 378-380 °C (MeOH). 1H NMR (DMSO): δ = 7.25-7.35 (m, 2 H, 2 × Ar-H), 7.55-7.57 (m, 2 H, 2 × Ar-H), 7.78-7.84 (m, 1 H, Ar-H), 7.95-8.07 (m, 3 H, 3 × Ar-H), 12.94 (br s, 1 H, NH). 13C NMR (TFAA): δ = 113.3 (CH), 121.0 (C), 123.5 (C), 125.1 (CH), 128.9 (CH), 130.2 (CH), 130.3 (CH), 130.4 (CH), 134.5 (CH), 135.1 (C), 136.2 (CH), 139.7 (C), 140.6 (C), 148.4 (C), 154.3 (C), 179.2 (2 × C=O). MS: m/z (%) = 247(44), 219(100). Compound 3b: Mp 151-153 ºC (MeOH). 1H NMR (CDCl3): δ = 1.18 (t, J = 7.0 Hz, 3 H, CH3), 3.30 (d, J = 18.5 Hz, 1 H, CHH), 3.91 (s, 3 H, OMe), 4.14 (q, J = 7.0 Hz, 2 H, CH2O), 4.51 (d, J = 18.0 Hz, 1 H, CHH), 6.91-6.99 (m, 2 H, 2 × ArH), 7.25 (s, 1 H, 2 × ArH), 7.41-7.54 (m, 2 H, 2 × ArH), 7.82 (d, J = 9.0 Hz, 1 H, ArH), 8.07 (d, J = 8.5 Hz, 1 H, ArH). 13C NMR (CDCl3): δ = 13.9 (CH3), 42.6 (CH2), 55.9 (CH3), 62.5 (CH2), 65.8 (C), 109.2 (CH), 116.5 (CH), 125.6 (CH), 126.7 (CH), 128.1 (C), 128.3 (CH), 129.6 (CH), 133.5 (CH), 135.7 (C), 148.7 (C), 156.8 (C), 166.5 (C), 168.2 (C=0), 198.6 (C=O). MS (CI): m/z
(%) = 356(1) [M+ + 1]; 266(100). Compound 4c: Mp 91-
93 ºC (MeOH). 1H NMR (CDCl3): δ = 3.37-3.43 (m, 1 H, CHH), 3.64 (s, 3 H, CO2Me), 3.68 (s, 3 H, CO2Me), 3.84
(s, 3 H, OMe), 3.96-4.01 (m, 1 H, CHH), 4.72 (t, J = 7.5 Hz, 1 H, CH), 6.41 (d, J = 3.0 Hz, 1 H, ArH), 6.72 (m, 1 H, ArH), 7.35-7.43 (m, 2 H, 2 × ArH), 7.49-7.51 (m, 1 H, ArH), 7.82 (d, J = 8.0 Hz, 1 H, ArH), 7.90 (d, J = 9.0 Hz, 1 H, ArH). 13C NMR (CDCl3): δ = 37.7 (CH2), 47.6 (CH3), 51.8 (CH3), 52.3 (CH3), 55.2 (CH), 112.2 (CH), 116.8 (CH), 121.5 (C), 124.7 (CH), 128.0 (CH), 131.0 (CH), 132.8 (CH), 133.3 (CH), 133.3 (C), 142.7 (C), 149.3 (C), 162.0 (C), 167.0 (C=O), 172.6 (C=O). MS (FAB): m/z (%) = 374(41) [M+ + 1], 154(100). Compound 5b: Mp 147-149 ºC (MeOH). 1H NMR (CDCl3): δ = 3.23-3.29 (m, 1 H, CHH),
3.79 (s, 3 H, OMe), 3.83 (s, 3 H, OMe), 3.85-3.89 (m, 2 H, CH, CHH), 6.70-6.90 (m, 5 H, 5 × ArH), 7.15 (t, J = 7.5 Hz, 1 H, ArH), 8.00 (d, J = 9.0 Hz, 1 H, ArH), 9.25 (s, 1 H, NH). 13C NMR (CDCl3): δ = 35.9 (CH2), 46.6 (CH), 51.7 (CH3), 55.3 (CH3), 109.7 (CH), 112.4 (CH), 117.6 (CH), 121.7 (CH), 121.8 (C), 124.9 (CH), 127.7 (CH), 129.2 (C), 133.4 (CH), 141.5 (C), 142.9 (C), 162.0 (C), 167.2 (C=O), 180.1 (C=O). MS: m/z (%) = 311(8) [M+], 279(100). Compound 6c: Mp 139-141 ºC (MeOH). 1H NMR (CDCl3): δ = 3.65 (s, 3 H, OMe), 3.93 (s, 3 H, OMe), 4.52 (d, J = 10.0 Hz, 2 H, CH2), 6.50-6.57 (m, 1 H, ArH), 6.71-6.75 (m, 1 H, ArH), 6.99-7.04 (m, 1 H, ArH), 7.12-7.16 (m, 1 H, ArH), 7.25-7.41 (m, 1 H, ArH), 7.99 (d, J = 9.0 Hz, 1 H, ArH), 8.21 (d, 1 H, ArH). 13C NMR (CDCl3): δ = 28.8 (CH2), 51.8 (CH3), 55.1 (CH3), 110.3 (CH), 110.4 (CH), 113.2 (C), 113.6 (C), 115.6 (CH), 118.7 (CH), 120.0 (CH), 121.5 (C), 122.2 (CH), 127.8 (C), 132.9 (CH), 136.1 (C), 144.3 (C), 162.3 (C), 167.7 (C=O). MS (FAB): m/z (%) = 376(3) [(M+ + 1) + 2], 374(5) [M+ + 1], 137(100). Compound 6d: Oil. 1H NMR (CDCl3): 3.73 (s, 3 H, OMe), 3.84 (s, 3 H, OMe), 4.54 (s, 2 H, CH2), 6.76-6.87 (m, 3 H, CH, 2 × ArH), 7.10 (t, J = 7.5 Hz, 1 H, ArH), 7.19 (t, J = 7.5 Hz, 1 H, ArH), 7.33 (d, J = 8.0 Hz, 1 H, ArH), 7.57 (d, J = 8.0 Hz, 1 H, ArH), 7.96-8.01 (m, 2 H, ArH, NH). 13C NMR (CDCl3): δ = 29.8 (CH2), 51.6 (OMe), 55.1 (OMe), 110.8 (CH), 111.0 (C), 115.2 (C), 116.4 (CH), 119.0 (CH), 119.2 (CH), 121.8 (C), 121.8 (CH), 122.6 (CH), 127.5 (C), 133.0 (CH), 136.3 (C), 145.6 (CH), 162.3 (C), 167.8 (C=O). MS: m/z (%) = 295(58) [M+], 220(100). Compound 7c: 206-208 ºC (MeOH). 1H NMR (CDCl3-acetone-DMSO): δ = 3.61 (s, 3 H, OMe), 3.64 (s, 3 H, OMe), 6.50-6.54 (m, 1 H, CH), 6.68-6.70 (m, 1 H, ArH), 6.79-6.84 (m, 2 H, ArH), 6.90-6.93 (m, 2 H, ArH), 7.89-7.95 (m, 2 H, ArH), 8.98 (br s, 1 H, NH). 13C NMR (CDCl3-acetone-DMSO): δ = 51.5 (CH3), 55.2 (CH3), 109.8 (CH), 114.1 (CH), 114.3 (CH), 121.0 (CH), 121.3 (C), 122.6 (CH), 126.8 (C), 129.2 (CH), 132.9 (CH), 137.2 (CH), 138.8 (C), 141.9 (C), 162.2 (C), 165.8 (C=O), 169.0 (C=O). MS: m/z (%) = 309 (12) [M+], 250(100). Compound 8d: Mp 386-388 °C (MeOH). 1H NMR (DMSO): δ = 3.87 (s, 3 H, OMe), 7.23-7.34 (m, 3 H, 3 × ArH), 7.43-7.54 (m, 1 H, ArH), 7.93-7.99 (m, 1 H, ArH), 8.53 (d, J = 8.6 Hz, 1 H, ArH), 12.8 (br s, 1 H, NH). 13C NMR (TFAA): δ = 54.8 (CH3), 111.3 (C), 112.7 (CH), 115.0 (C), 117.5 (CH), 119.6 (CH), 120.5 (C), 125.3 (CH), 129.9 (CH), 130.4 (CH), 130.6 (C), 132.2 (CH), 140.5 (C), 150.0 (C), 153.8 (C), 165.5 (C), 179.3 (2 × C=O). MS: m/z (%) = 277(42) [M+], 29(100).